GSK2236805
Modify Date: 2024-01-02 19:03:36
GSK2236805 structure
|
Common Name | GSK2236805 | ||
|---|---|---|---|---|
| CAS Number | 1256390-53-0 | Molecular Weight | 796.91 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 1115.3±65.0 °C at 760 mmHg | |
| Molecular Formula | C42H52N8O8 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 628.3±34.3 °C | |
Use of GSK2236805GSK2236805 is a potent hepatitis C virus inhibitor with pEC50 values of 10.4, 11.1 for HCV genotype 1a (gt1a) and gt1b, respectively[1]. |
| Name | GSK-2336805 |
|---|---|
| Synonym | More Synonyms |
| Description | GSK2236805 is a potent hepatitis C virus inhibitor with pEC50 values of 10.4, 11.1 for HCV genotype 1a (gt1a) and gt1b, respectively[1]. |
|---|---|
| Related Catalog | |
| Target |
pEC50: 10.4 (gt1a); 11.1 µM (gt1b)[1] |
| References |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 1115.3±65.0 °C at 760 mmHg |
| Molecular Formula | C42H52N8O8 |
| Molecular Weight | 796.91 |
| Flash Point | 628.3±34.3 °C |
| Exact Mass | 796.390808 |
| LogP | 5.44 |
| Vapour Pressure | 0.0±0.3 mmHg at 25°C |
| Index of Refraction | 1.644 |
| Carbamic acid, N-[(1S)-1-[[(2S)-2-[5-[4'-[2-[(8S)-7-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-1,4-dioxa-7-azaspiro[4.4]non-8-yl]-1H-imidazol-5-yl][1,1'-biphenyl]-4-yl]-1H-imidazol-2-yl]-1-pyrrolidinyl]carbonyl]-2-methylpropyl]-, methyl ester |
| MFCD28963895 |
| Methyl [(2S)-1-{(8S)-8-[4-(4'-{2-[(2S)-1-{(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl}-2-pyrrolidinyl]-1H-imidazol-4-yl}-4-biphenylyl)-1H-imidazol-2-yl]-1,4-dioxa-7-azaspiro[4.4]non-7-yl}-3-methyl-1-oxo-2-butanyl]carbamate |
| GSK-2336805 |